InvestorsHub Logo
Followers 1172
Posts 171799
Boards Moderated 4
Alias Born 12/20/2003

Re: None

Tuesday, 05/30/2017 8:38:38 AM

Tuesday, May 30, 2017 8:38:38 AM

Post# of 216
Cerecor to present at the American Society for Clinical Psychopharmacology Conference


BALTIMORE, MD--(Marketwired - May 30, 2017) - Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing treatments to make a difference in the lives of patients with neurological and psychiatric disorders, today announced that Ronald Marcus MD, Chief Medical Officer, will present at the American Society for Clinical Psychopharmacology Conference in Miami Beach on May 30th, 2017. The presentation is titled "A Clinical Development program in Psychiatry for a Selective Kappa Antagonist" and is focused on the results from a previously reported National Institute of Mental health of the National Institutes of Health sponsored proof-of concept study of CERC-501 in treatment resistant depression

History.htm